Search Prime Grants

R33HL147908

Project Grant

Overview

Grant Description
Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (ASTHMA-PASS) - Project Summary/Abstract

Asthma prevalence in Bronx, NY schools is 20-25%. Physical activity (PA) is an important component of asthma management in children. Studies show that PA is associated with decreased severity of asthma symptoms, as well as improved disease control and quality of life. However, urban minority children with asthma face barriers to PA on multiple levels.

In our prior work (K23HD065742), we identified several barriers to PA in urban minority schoolchildren with asthma. These barriers include inadequate access to asthma rescue medications in school, suboptimal prescribing of preventive asthma therapy by primary care physicians (PCPs), lack of school PA opportunities, stigma associated with asthma, parent/child fear of an asthma attack with PA, and lack of teacher confidence in assisting students with asthma.

We developed a novel asthma management program to promote activity for students in schools (ASTHMA-PASS) in collaboration with stakeholders to address these key barriers. We pilot tested ASTHMA-PASS with 109 students with asthma from 4 Bronx elementary schools and their parents to demonstrate proof of concept and preliminary evidence of intervention effectiveness. Results from the pilot study demonstrated significantly greater increase in symptom-free days (SFDS) (primary outcome measure) and PA levels. In addition, preliminary mediation analyses suggested vigorous PA and step counts are mediators of SFDS.

We now plan to build upon this work and evaluate in a full-scale randomized trial whether the ASTHMA-PASS intervention reduces asthma morbidity among high-risk urban schoolchildren. We propose a cluster-randomized controlled trial with 416 children ages 5-11 years with persistent or uncontrolled asthma from 26 Bronx schools. Schools will be stratified by size and then randomly assigned to either (1) the ASTHMA-PASS intervention (PCP collaboration to ensure optimal guideline-based preventive asthma care and community health workers to facilitate rescue medication availability in school and provide asthma awareness programming and education for children, parents, and school personnel to reduce stigma around asthma and PA) or (2) an asthma management (AM) comparison group (PCP and parent notification of child's asthma status and general asthma education). Both groups will participate in an existing district-wide classroom-based daily activity program ('Move to Improve').

We will assess the effectiveness of ASTHMA-PASS in reducing asthma morbidity (primary outcome - SFDS), and improving PA (secondary outcome) as well as additional clinical and functional outcomes. We will measure PA with accelerometers using previously established procedures. We will also identify potential mediators and moderators of the intervention effect. We will evaluate the process of intervention implementation by applying the RE-AIM framework.

This proposal directly builds on our prior work in schools to improve asthma outcomes and reduce health disparities. If ASTHMA-PASS successfully reduces symptoms and improves health, it will provide a powerful argument for policy change in schools and urban communities nationwide.
Funding Goals
NOT APPLICABLE
Place of Performance
Bronx, New York 10461 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 352% from $835,944 to $3,779,467.
Albert Einstein College Of Medicine was awarded Asthma-PASS: Promoting Activity for Urban Schoolchildren with Asthma Project Grant R33HL147908 worth $3,779,467 from National Heart Lung and Blood Institute in September 2020 with work to be completed primarily in Bronx New York United States. The grant has a duration of 5 years and was awarded through assistance program 93.837 Cardiovascular Diseases Research. The Project Grant was awarded through grant opportunity Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required).

Status
(Complete)

Last Modified 9/20/24

Period of Performance
9/24/20
Start Date
8/31/25
End Date
100% Complete

Funding Split
$3.8M
Federal Obligation
$0.0
Non-Federal Obligation
$3.8M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R33HL147908

Transaction History

Modifications to R33HL147908

Additional Detail

Award ID FAIN
R33HL147908
SAI Number
R33HL147908-1402115688
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Funding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Awardee UEI
H6N1ZF5HJ2G3
Awardee CAGE
87UV8
Performance District
NY-14
Senators
Kirsten Gillibrand
Charles Schumer

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) Health research and training Grants, subsidies, and contributions (41.0) $2,125,809 100%
Modified: 9/20/24